[Comparison of EGIL1998 and WHO2008 criteria for the diagnosis of mixed phenotype acute leukemia].
Ye L, Lin D, Mi YC, Zhang J, Wang Y, Wang HJ, Wei H, Liu BC, Zhou CL, Li W, Wang JX.
Zhonghua Xue Ye Xue Za Zhi. 2012 Apr;33(4):286-90.
A novel small molecule that kills a subset of MLL-rearranged leukemia cells by inducing mitochondrial dysfunction.
Somers K, Wen VW, Middlemiss SMC, Osborne B, Forgham H, Jung M, Karsa M, Clifton M, Bongers A, Gao J, Mayoh C, Raoufi-Rad N, Kusnadi EP, Hannan KM, Scott DA, Kwek A, Liu B, Flemming C, Chudakova DA, Pandher R, Failes TW, Lim J, Angeli A, Osterman AL, Imamura T, Kees UR, Supuran CT, Pearson RB, Hannan RD, Davis TP, McCarroll J, Kavallaris M, Turner N, Gudkov AV, Haber M, Norris MD, Henderson MJ.
Oncogene. 2019 May;38(20):3824-3842. doi: 10.1038/s41388-018-0666-5. Epub 2019 Jan 22.
[A study of mixed phenotype acute leukemia based on the 2008 World Health Organization classification].
Park J, Chae H, Kim M, Lim J, Kim Y, Lee J, Chung NG, Cho B, Kim HK, Lee S, Han K.
Korean J Lab Med. 2010 Dec;30(6):525-32. doi: 10.3343/kjlm.2010.30.6.525.
